Healthy Extracts (HYEX) Net Income towards Common Stockholders Growth (3y) (2018 - 2026)
Healthy Extracts (HYEX) Net Income towards Common Stockholders Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 14.04% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 2.87% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 14.78% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn | 66.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.93% |
| Dec 31, 2025 | -37.77% |
| Sep 30, 2025 | -32.35% |
| Jun 30, 2025 | 37.06% |
| Mar 31, 2025 | -69.04% |
| Dec 31, 2024 | 33.57% |
| Sep 30, 2024 | 60.82% |
| Jun 30, 2024 | 4.52% |
| Mar 31, 2024 | 19.77% |
| Dec 31, 2023 | 40.24% |
| Sep 30, 2023 | -84.67% |
| Jun 30, 2023 | -77.95% |
| Mar 31, 2023 | 39.89% |
| Dec 31, 2022 | 30.56% |
| Sep 30, 2022 | -225.34% |
| Jun 30, 2022 | -76.13% |
| Mar 31, 2022 | 38.58% |
| Dec 31, 2021 | -146.31% |
| Sep 30, 2021 | -58.71% |
| Jun 30, 2021 | -21.78% |